270 related articles for article (PubMed ID: 17381502)
1. Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.
Icks A; Rathmann W; Haastert B; Gandjour A; Holle R; John J; Giani G;
Diabet Med; 2007 May; 24(5):473-80. PubMed ID: 17381502
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
Schaufler TM; Wolff M
Appl Health Econ Health Policy; 2010; 8(3):191-202. PubMed ID: 20408603
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
Lindgren P; Lindström J; Tuomilehto J; Uusitupa M; Peltonen M; Jönsson B; de Faire U; Hellénius ML;
Int J Technol Assess Health Care; 2007; 23(2):177-83. PubMed ID: 17493303
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
[TBL] [Abstract][Full Text] [Related]
6. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
Palmer AJ; Tucker DM
Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
[TBL] [Abstract][Full Text] [Related]
7. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
8. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden.
Johansson P; Ostenson CG; Hilding AM; Andersson C; Rehnberg C; Tillgren P
Int J Technol Assess Health Care; 2009 Jul; 25(3):350-8. PubMed ID: 19619354
[TBL] [Abstract][Full Text] [Related]
10. Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN).
Wolf AM; Siadaty M; Yaeger B; Conaway MR; Crowther JQ; Nadler JL; Bovbjerg VE
J Am Diet Assoc; 2007 Aug; 107(8):1365-73. PubMed ID: 17659904
[TBL] [Abstract][Full Text] [Related]
11. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus.
Franz MJ; Splett PL; Monk A; Barry B; McClain K; Weaver T; Upham P; Bergenstal R; Mazze RS
J Am Diet Assoc; 1995 Sep; 95(9):1018-24. PubMed ID: 7657903
[TBL] [Abstract][Full Text] [Related]
13. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.
Kramer MK; Kriska AM; Venditti EM; Miller RG; Brooks MM; Burke LE; Siminerio LM; Solano FX; Orchard TJ
Am J Prev Med; 2009 Dec; 37(6):505-11. PubMed ID: 19944916
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM; Schlessinger L; Kahn R
Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
[TBL] [Abstract][Full Text] [Related]
16. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions.
Dalziel K; Segal L
Health Promot Int; 2007 Dec; 22(4):271-83. PubMed ID: 17916604
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M
Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767
[TBL] [Abstract][Full Text] [Related]
18. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
Hoerger TJ; Hicks KA; Sorensen SW; Herman WH; Ratner RE; Ackermann RT; Zhang P; Engelgau MM
Diabetes Care; 2007 Nov; 30(11):2874-9. PubMed ID: 17698614
[TBL] [Abstract][Full Text] [Related]
20. Using an economic model of diabetes to evaluate prevention and care strategies in Australia.
Colagiuri S; Walker AE
Health Aff (Millwood); 2008; 27(1):256-68. PubMed ID: 18180502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
